3d
MedPage Today on MSNFor Your Patients: What Is Multiple Myeloma?Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
3d
MedPage Today on MSNThe Basics of Multiple MyelomaIn spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...
Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...
Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...
Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.
Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...
An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...
After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...
Welcome Home of Chattanooga is celebrating 10 years of service to the Tennessee Valley. To kick off their 10 year anniversary ...
Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results